Back to Search Start Over

Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies

Authors :
Luís Taborda-Barata
Joana Carvalho
Diana Bordalo
Cristina Jácome
Ana Margarida Pereira
Rute Almeida
Manuel Ferreira-Magalhaes
Cláudia Chaves Loureiro
Cristina Lopes
Carmelita Ribeiro
Carlos Lozoya
Natacha Santos
Maria João Vasconcelos
Pedro Morais Silva
Raquel Câmara
Rosário Ferreira
Maria José Calix
Carlos Nunes
Joao A Fonseca
Sara Fernandes
Rosália Páscoa
Luís Monteiro
Carmen Vidal
Darío Antolín-Amérigo
Mafalda Simões Cunha
Rita Amaral
Magna Alves-Correia
Diana Pinto
Francisca Cardia
Tania Monteiro Ferreira
Eurico Silva
Cristina Guimarães
Sofia da Silva
Maria Luís Marques
Ana Morete
Cláudia Vieira
Adelaide Alves
José Varanda Marques
Bruno Reis
Rosário Monteiro
Margarida Cepa
Bruno Valentim
Daniela Sousa Coelho
Patrícia Meireles
Margarida Abreu Aguiar
Ana Rita Mourão
Source :
BMJ Open, Vol 13, Iss 5 (2023)
Publication Year :
2023
Publisher :
BMJ Publishing Group, 2023.

Abstract

Objectives Anxiety and depression are relevant comorbidities in asthma, but, in Portugal and Spain, data on this topic are scarce. We assessed, in patients with asthma, the frequency of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and the European Quality of Life Five Dimension Questionnaire (EQ-5D); the level of agreement between these questionnaires, and the factors associated with these symptoms.Methods This is a secondary analysis of the INSPIRERS studies. A total of 614 adolescents and adults with persistent asthma (32.6±16.9 years, 64.7% female) were recruited from 30 primary care centres and 32 allergy, pulmonology and paediatric clinics. Demographic and clinical characteristics, HADS and EQ-5D were collected. A score ≥8 on Hospital Anxiety and Depression Scale-Anxiety/Hospital Anxiety and Depression Scale-Depression or a positive answer to EQ-5D item 5 indicated the presence of these symptoms. Agreement was determined by Cohen’s kappa. Two multivariable logistic regressions were built.Results According to HADS, 36% of the participants had symptoms of anxiety and 12% of depression. According to EQ-5D, 36% of the participants had anxiety/depression. The agreement between questionnaires in identifying anxiety/depression was moderate (k=0.55, 95% CI 0.48 to 0.62). Late asthma diagnosis, comorbidities and female gender were predictors of anxiety/depression, while better asthma control, health-related quality of life and perception of health were associated with lower odds for anxiety/depression.Conclusion At least 1/3 of the patients with persistent asthma experience symptoms of anxiety/depression, showing the relevance of screening these disorders in patients with asthma. EQ-5D and HADS questionnaires showed a moderate agreement in the identification of anxiety/depression symptoms. The identified associated factors need to be further investigated in long-term studies.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
20446055
Volume :
13
Issue :
5
Database :
Directory of Open Access Journals
Journal :
BMJ Open
Publication Type :
Academic Journal
Accession number :
edsdoj.374d033cbc4759946769f83815f87c
Document Type :
article
Full Text :
https://doi.org/10.1136/bmjopen-2022-068725